Sarah Jones Simmer, the CEO of Found, said there are plenty of other FDA-approved drugs the company can prescribe when GLP-1 injections aren't available
For others, the drug improves the kind of test results doctors watch as early warning signs of disease (blood pressure, cholesterol, kidney markers), but the trials that would tell us whether the things we actually care about (heart attacks, strokes, kidney failure) also improve have not yet been reported
Y., Qi, Y., Liao, P., Darakhshan, S., Farzaei, M
Continued scrutiny of drug pricing appears likely, particularly given the rapidly evolving and uncertain US drug pricing environment, adding uncertainty for the companies set to enter the GLP-1 space
January savings and support This month at Pharmacy Innovations , we are highlighting New Year weight-management support